Allergy/Imm

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Chen M et al. – The results from both in vitro and in vivo experiments indicate that IFN–beta treatment can down–regulate the OPN and IL–17 production in MS. This study provides new insights into the mechanism of action of IFN–beta in the treatment of MS.

Related Articles

Reevaluation of the role of duration of morning stiffness in the assessment of rheumatoid arthritis activity
Journal of Rheumatology, 10/21/09    Relevance Score: 94%

A longitudinal study of cognition in nursing home residents with multiple sclerosis
Disability & Rehabilitation, 11/04/09    Relevance Score: 91%

Multiple sclerosis. Part 2: Ophthalmic issues in MS therapy
Current Opinion in Ophthalmology, 10/29/09    Relevance Score: 90%

Coupling of LC-MS/MS and LC-SPE-NMR techniques for the structural identification of metabolites following in vitro biotransformation of SUR1-selective KATP channel openers
Drug Metabolism and Disposition, 11/20/09    Relevance Score: 89%

Discovery and identification of potential biomarkers of papillary thyroid carcinoma
Molecular Cancer, 10/02/09    Relevance Score: 89%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address